This inventor holds 1 USPTO granted patent. Top assignee: Adrx, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Matthew A G Graf: Innovator in Tau Aggregation Peptide Inhibitors
Introduction
Matthew A G Graf is a notable inventor based in Ventura, California. He has made significant contributions to the field of amyloid therapeutics, particularly through his work on tau aggregation peptide inhibitors. His innovative approach addresses critical health issues associated with tau aggregation.
Latest Patents
Matthew holds a patent for tau aggregation peptide inhibitors. This invention focuses on pharmaceutical compositions and methods for treating conditions or diseases associated with aggregation. His work is pivotal in developing new therapeutic options for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
Matthew is currently employed at Adrx, Inc., where he continues to advance his research in the field of pharmaceuticals. His expertise in tau aggregation inhibitors positions him as a key player in the development of new treatments.
Collaborations
Matthew collaborates with talented individuals such as Shiho Tanaka and Ashley Wright. Their combined efforts contribute to the innovative research and development at Adrx, Inc.
Conclusion
Matthew A G Graf is a dedicated inventor whose work in tau aggregation peptide inhibitors is making a significant impact in the field of amyloid therapeutics. His contributions are essential for advancing treatment options for aggregation-associated conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile